Literature DB >> 4163708

Studies of human anti-gamma-globulin factors reacting with pepsin-digested gamma-globulins.

T G Lawrence, R C Williams.   

Abstract

Many sera from normal individuals as well as patients with various disease states contain agglutinating antibodies which show specificity for antigenic determinants of gamma-globulin revealed by pepsin digestion at pH 4.1. Sera containing such agglutinating activity as well as sera negative for these agglutinators contain low molecular weight (3S-5S) components of slow gamma-mobility which inhibit these agglutination reactions. Low molecular weight inhibitors show both auto- and isospecificity, and are antigenically related to the 5S pepsin fragment of gamma-globulin. A common situation is thereby revealed in which human anti-gamma-globulin antibodies showing specificity for pepsin-digested gamma-globulins are present in serum along with low molecular weight gamma-globulin components capable of inhibition. Autoreactivity or autospecificity of such anti-gamma-globulin factors is a phenomenon shared by both normal human sera and sera from patients with various disease states.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163708      PMCID: PMC2138353          DOI: 10.1084/jem.125.2.233

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  LOW MOLECULAR WEIGHT GAMMA-GLOBULINS OF URINE AND PLASMA AND THEIR RELATION TO 7S GAMMA-2-GLOBULIN.

Authors:  P FIREMAN; E HERSHGOLD; F CORDOBA; K SCHMID; D GITLIN
Journal:  Nature       Date:  1964-07-04       Impact factor: 49.962

2.  CHEMICAL STUDIES ON IMMUNOGLOBULINS. I. A NEW PREPARATIVE PROCEDURE FOR GAMMA-GLOBULINS EMPLOYING GLYCINE-RICH SOLVENT SYSTEMS.

Authors:  J PORATH; N UI
Journal:  Biochim Biophys Acta       Date:  1964-08-19

3.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

4.  A serum with an albumin-active, auto-agglutinating property.

Authors:  B P MOORE; I LININS; J McINTYRE
Journal:  Blood       Date:  1959-04       Impact factor: 22.113

5.  Zone electrophoresis.

Authors:  H G KUNKEL
Journal:  Methods Biochem Anal       Date:  1954

6.  Heterogeneity of anti-gamma-globulin factors detected by pepsin-digested human gamma G-globulin.

Authors:  J B Natvig
Journal:  Acta Pathol Microbiol Scand       Date:  1966

7.  Light-chain disease. An abortive variant of multiple myeloma.

Authors:  R C Williams; R D Brunning; F A Wollheim
Journal:  Ann Intern Med       Date:  1966-09       Impact factor: 25.391

8.  Reaction of human anti-antibodies with incomplete anti-D and its sub-units.

Authors:  J B Natvig
Journal:  Acta Pathol Microbiol Scand       Date:  1966

9.  Variations among gamma-globulins at the antigenic site revealed by pepsin digestion.

Authors:  R C Williams; T G Lawrence
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

10.  The in vivo formation and fate of antigen-antibody complexes formed by fragments and polypeptide chains of rabbit gamma-G-antibodies.

Authors:  H L Spiegelberg; W O Weigle
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

View more
  13 in total

1.  Naturally occurring antiglobulin factors in virus neutralization: homoreactant as a factor enhancing neutralization of the infectious complex of poliovirus with the Fab' antibody fragment.

Authors:  A J Kulberg; J V Pervikov
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

2.  Evidence for immune complexes containing antibody to the pepsin site of IgG in rheumatoid synovial fluids.

Authors:  O J Mellbye; J B Natvig
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

3.  The relationship between rheumatoid factors and serum agglutinators.

Authors:  M Waller
Journal:  Immunology       Date:  1967-12       Impact factor: 7.397

4.  Naturally occurring pepsin agglutinators in the serum of subhuman primates.

Authors:  S D Litwin
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

5.  Human anti-gamma-globulin antibodies specific for gamma G heavy chain subclasses.

Authors:  J B Natvig
Journal:  Immunology       Date:  1970-07       Impact factor: 7.397

6.  Anti-globulin antibodies detecting hidden gamma G antigens: characterization of the "pepsin site" by different immune antisera.

Authors:  S D Litwin
Journal:  Immunology       Date:  1970-09       Impact factor: 7.397

7.  IgG hydrolysis in abscesses. I. A study of the IgG in human abscess fluid.

Authors:  M Waller
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

8.  Serum agglutinators in families with twins.

Authors:  M Waller; N Curry
Journal:  Immunology       Date:  1971-08       Impact factor: 7.397

9.  Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

10.  Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation).

Authors:  E Plow; T S Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.